Rep. Lizzie Fletcher Sells Off Shares of McKesson Corporation (NYSE:MCK)

Key Points

• Representative Lizzie Fletcher sold between $1,001 and $15,000 of McKesson (NYSE:MCK) stock on April 8 (disclosed May 1) and executed similar-sized sales of several other large-cap names the same day.
• McKesson reported an earnings beat (Q EPS $9.34 vs. $9.19) with revenue up 11.4% year-over-year, set FY2026 EPS guidance of $38.80–$39.20, and carries a consensus analyst target near $972 with a market cap of about $99.8 billion.
• The company announced a quarterly dividend of $0.82 (annualized $3.28, yield ~0.4%), insiders sold roughly 3,592 shares (~$3.52M) last quarter, and institutional investors own about 85% of the stock.

Representative Lizzie Fletcher (Democratic-Texas) recently sold shares of McKesson Corporation NYSE: MCK. In a filing disclosed on May 01st, the Representative disclosed that they had sold between $1,001 and $15,000 in McKesson stock on April 8th. The trade occurred in the Representative's "FILER BROKERAGE ACCOUNT (CB)" account.

Representative Lizzie Fletcher also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Apple NASDAQ: AAPL on 4/8/2026.
• Sold $1,001 - $15,000 in shares of KLA NASDAQ: KLAC on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Eaton NYSE: ETN on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/8/2026.
• Sold $1,001 - $15,000 in shares of JPMorgan Chase & Co. NYSE: JPM on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Quanta Services NYSE: PWR on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Alphabet NASDAQ: GOOGL on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Ameriprise Financial NYSE: AMP on 4/8/2026.
• Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 4/8/2026.
• Sold $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/8/2026.

McKesson Stock Performance

Shares of MCK stock opened at $814.69 on Friday. The stock's 50 day simple moving average is $894.86 and its 200 day simple moving average is $859.16. McKesson Corporation has a twelve month low of $637.00 and a twelve month high of $999.00. The company has a market capitalization of $99.79 billion, a price-to-earnings ratio of 23.43, a PEG ratio of 1.18 and a beta of 0.35.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period last year, the business earned $8.03 EPS. The firm's revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, analysts forecast that McKesson Corporation will post 39.02 EPS for the current fiscal year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, June 1st. McKesson's dividend payout ratio (DPR) is presently 9.43%.

Insider Transactions at McKesson

In other news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company's stock, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The SEC filing for this sale provides additional information. Insiders sold a total of 3,592 shares of company stock worth $3,518,555 over the last quarter. 0.08% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

MCK has been the topic of a number of recent analyst reports. Evercore reissued an "outperform" rating on shares of McKesson in a research note on Thursday, March 5th. Wall Street Zen raised McKesson from a "hold" rating to a "buy" rating in a research note on Saturday. William Blair initiated coverage on McKesson in a research note on Tuesday. They issued an "outperform" rating on the stock. Leerink Partners reissued an "outperform" rating and issued a $1,085.00 price objective on shares of McKesson in a research note on Thursday, March 5th. Finally, JPMorgan Chase & Co. lifted their price target on McKesson from $983.00 to $1,107.00 and gave the stock an "overweight" rating in a research report on Tuesday, February 10th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $972.27.

Institutional Trading of McKesson

Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of McKesson by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 12,104,719 shares of the company's stock worth $9,929,380,000 after purchasing an additional 73,109 shares in the last quarter. State Street Corp grew its holdings in shares of McKesson by 0.5% during the 4th quarter. State Street Corp now owns 5,780,179 shares of the company's stock worth $4,746,118,000 after purchasing an additional 29,660 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of McKesson by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 2,857,344 shares of the company's stock worth $2,333,520,000 after purchasing an additional 25,082 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of McKesson by 5.4% during the 4th quarter. Franklin Resources Inc. now owns 2,825,954 shares of the company's stock worth $2,318,102,000 after purchasing an additional 144,633 shares in the last quarter. Finally, Alliancebernstein L.P. grew its holdings in shares of McKesson by 5.6% during the 3rd quarter. Alliancebernstein L.P. now owns 2,394,699 shares of the company's stock worth $1,850,001,000 after purchasing an additional 126,684 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

About Representative Fletcher

Lizzie Pannill Fletcher (Democratic Party) is a member of the U.S. House, representing Texas' 7th Congressional District. She assumed office on January 3, 2019. Her current term ends on January 3, 2027. Fletcher (Democratic Party) ran for re-election to the U.S. House to represent Texas' 7th Congressional District. She won in the general election on November 5, 2024. Lizzie Pannill Fletcher was born and lives in Houston, Texas. She graduated from St. John's School. She earned a bachelor's degree in history from Kenyon College and a J.D. from William & Mary Law School. Fletcher’s career experience includes working as a lawyer. She co-founded Planned Parenthood Young Leaders in 2000. Fletcher serves as a board member of Writers in the Schools and Open Dance Project.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.